In market activity today, Oncolytics Bio shares closed at $1.34 after opening the day at $1.37. It traded at a low of $1.32 to a high of $1.38.

Shares dipped -3.60% from the previous day's close of $1.39.

Today across North America, the TSX Composite closed -0.64% at 21829.85, the S&P 500 closed -0.29% at 5150.48, the Dow Jones Industrial Average closed -0.35% at 38905.66 and the Nasdaq Composite closed -0.30% at 16128.53.

Oncolytics Bio has listed on the Toronto Stock Exchange (TSX) under the ticker ONC.

A total of 74,813 shares was traded during the last trading day, with total trades of 180. On average, Oncolytics Bio has traded 45,431 shares in the last five days and 78,967 year-to-date.

The TSX overall saw 3,000 price advancers against 2,251 declines and 118 unchanged.

During the prior 52 weeks, ONC.TO has traded as high as $4.49 (June 23,2023) and low as $1.20 (February 07,2024). Moreover, in the last 12 months, Oncolytics Bio's shares have shrunken -25.97 percent, while they have shrunken -25.14% year-to-date.

Following today's trading, Oncolytics Bio has a market capitalization of $104.83 million on a float of 75,420 shares outstanding. Its annual EPS is $-0.41.

Oncolytics Bio is a TSX Biotechnology company headquartered in Calgary, CAN.

Oncolytics Bio's average recommendation is "Strong Buy" based on 5.00 analysts according to Zacks. Currently, there are 5 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..